Literature DB >> 33875890

COVID-19 dynamics after a national immunization program in Israel.

Malka Gorfine1, Uri Shalit2, Eran Segal3,4, Hagai Rossman5,6, Smadar Shilo5,6,7, Tomer Meir5,6.   

Abstract

Studies on the real-life effect of the BNT162b2 vaccine for Coronavirus Disease 2019 (COVID-19) prevention are urgently needed. In this study, we conducted a retrospective analysis of data from the Israeli Ministry of Health collected between 28 August 2020 and 24 February 2021. We studied the temporal dynamics of the number of new COVID-19 cases and hospitalizations after the vaccination campaign, which was initiated on 20 December 2020. To distinguish the possible effects of the vaccination on cases and hospitalizations from other factors, including a third lockdown implemented on 8 January 2021, we performed several comparisons: (1) individuals aged 60 years and older prioritized to receive the vaccine first versus younger age groups; (2) the January lockdown versus the September lockdown; and (3) early-vaccinated versus late-vaccinated cities. A larger and earlier decrease in COVID-19 cases and hospitalization was observed in individuals older than 60 years, followed by younger age groups, by the order of vaccination prioritization. This pattern was not observed in the previous lockdown and was more pronounced in early-vaccinated cities. Our analysis demonstrates the real-life effect of a national vaccination campaign on the pandemic dynamics.

Entities:  

Year:  2021        PMID: 33875890     DOI: 10.1038/s41591-021-01337-2

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  66 in total

1.  Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.

Authors:  Ralf Duerr; Dacia Dimartino; Christian Marier; Paul Zappile; Guiqing Wang; Jennifer Lighter; Brian Elbel; Andrea B Troxel; Adriana Heguy
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

2.  Compounders of the COVID crisis: the "perfect storm".

Authors:  Barry A Franklin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-08-23

3.  Uninformative and unuseful: why it is necessary to actively challenge COVID-19 antibody testing postvaccination.

Authors:  D Romero-Alvarez; D F López-Cevallos; I Torres
Journal:  Public Health       Date:  2021-08-25       Impact factor: 2.427

4.  Which vaccination strategy against COVID-19?

Authors:  Alessandro De Matteis; Fethiye B Turkmen Ceylan; Enrico Urpis
Journal:  Int Health       Date:  2022-05-27       Impact factor: 3.131

5.  National Scale Real-Time Surveillance of SARS-CoV-2 Variants Dynamics by Wastewater Monitoring in Israel.

Authors:  Itay Bar-Or; Victoria Indenbaum; Merav Weil; Michal Elul; Nofar Levi; Irina Aguvaev; Zvi Cohen; Virginia Levy; Roberto Azar; Batya Mannasse; Rachel Shirazi; Efrat Bucris; Orna Mor; Alin Sela Brown; Danit Sofer; Neta S Zuckerman; Ella Mendelson; Oran Erster
Journal:  Viruses       Date:  2022-06-06       Impact factor: 5.818

Review 6.  COVID-19 Critical Illness: A Data-Driven Review.

Authors:  Jennifer C Ginestra; Oscar J L Mitchell; George L Anesi; Jason D Christie
Journal:  Annu Rev Med       Date:  2021-09-14       Impact factor: 16.048

7.  Will achieving herd immunity be a road to success to end the COVID-19 pandemic?

Authors:  Kin On Kwok; Edward B McNeil; Margaret Ting Fong Tsoi; Vivian Wan In Wei; Samuel Yeung Shan Wong; Julian Wei Tze Tang
Journal:  J Infect       Date:  2021-06-10       Impact factor: 38.637

8.  BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel.

Authors:  Tal Brosh-Nissimov; Efrat Orenbuch-Harroch; Michal Chowers; Meital Elbaz; Lior Nesher; Michal Stein; Yasmin Maor; Regev Cohen; Khetam Hussein; Miriam Weinberger; Oren Zimhony; Bibiana Chazan; Ronza Najjar; Hiba Zayyad; Galia Rahav; Yonit Wiener-Well
Journal:  Clin Microbiol Infect       Date:  2021-07-07       Impact factor: 8.067

Review 9.  Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors:  Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

Review 10.  COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures.

Authors:  Robert Rosolanka; Andres F Henao-Martinez; Larissa Pisney; Carlos Franco-Paredes; Martin Krsak
Journal:  Ther Adv Infect Dis       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.